# Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients

> **NCT00430469** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **AM-Pharma**

## Conditions studied

- Fungal Infection
- Bacterial Infection

## Interventions

- **DRUG:** human lactoferrin (hLF1-11)

## Key facts

- **NCT ID:** NCT00430469
- **Lead sponsor:** AM-Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-11
- **Primary completion:** 2009-03
- **Final completion:** 2009-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Strategic company decision
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00430469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00430469, "Safety of hLF1-11 for the Treatment of Infectious Complications Among HSCT Recipients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00430469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*